The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses
Abstract
Through the Advisory Committee on Dengue and other Flavivirus Vaccines, the World Health Organization(WHO) has had a long-standing commitment to facilitate and to guide research and development of vaccines for medically important flaviviruses. Recently, the Paediatric Dengue Vaccine Initiative (PDVI) was formed to accelerate the development, testing, and introduction of dengue (DEN)vaccines worldwide, partnering with WHO in this important public health effort. There are now a variety of DEN vaccines in various stages of the developmental pipeline. In an attempt to make interlaboratory information more directly comparable, WHO with the support of PDVI initiated a program to coordinate the procedures used for the plaque-reduction neutralization test (PRNT). ThePRNT is the most common assay used to measure neutralizing antibody. The presence of antibody is believed to be most relevant means of determining protective anti-DEN virus (DENV) immunity. While other neutralizing antibody assays are being considered for use in large-scale vaccine field trials, the PRNT is still considered to be the laboratory standard against which other neutralizing antibody assays should be compared. The need for PRNT coordination has been identified at several consultations between the WHO and PDVI. A more complete version of these guidelines is available on the WHO website: http://www.who.int/immunization/documents/date/en/index.html.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuhn, R. J., Zhang, W., Rossmann, M. G., Pletnev, S. V., Corver, J., Lenches, E., Jones, C. T., Mukhopadhyay, S., Chipman, P. R., Strauss, E. G., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00660-8 · Cited by 1,563
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C., & Harrison, S. C. (1995) · Nature · doi:10.1038/375291a0 · Cited by 1,437
Structure of the dengue virus envelope protein after membrane fusion
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2004) · Nature · doi:10.1038/nature02165 · Cited by 1,203
A ligand-binding pocket in the dengue virus envelope glycoprotein
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832193100 · Cited by 1,061
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804
Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane fusion conformation
Bressanelli, S., Stiasny, K., Allison, S. L., Stura, E. A., Duquerroy, S., Lescar, J., Heinz, F. X., & Rey, F. A. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600064 · Cited by 593
Kliks, S. C., Nimmanitya, S., Nisalak, A., & Burke, D. S. (1988) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.411 · Cited by 578
Dengue and dengue hemorrhagic fever
Gubler, D. J. (1997) · Seminars in Pediatric Infectious Diseases · doi:10.1016/s1045-1870(97)80003-9 · Cited by 569
Antibody-enhanced dengue virus infection in primate leukocytes
HALSTEAD, S. B., & O'ROURKE, E. J. (1977) · Nature · doi:10.1038/265739a0 · Cited by 550
Kliks, S. C., Nisalak, A., Brandt, W. E., Wahl, L., & Burke, D. S. (1989) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1989.40.444 · Cited by 517
Structures of immature flavivirus particles
Zhang, Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg270 · Cited by 499
Conformational Changes of the Flavivirus E Glycoprotein
Zhang, Y., Zhang, W., Ogata, S. A., Clements, D. E., Strauss, J. H., Baker, T. S., Kuhn, R. J., & Rossmann, M. G. (2004) · Structure · doi:10.1016/j.str.2004.06.019 · Cited by 480
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus
Zhang, W., Chipman, P. R., Corver, J., Johnson, P. R., Zhang, Y., Mukhopadhyay, S., Baker, T. S., Strauss, J. H., Rossmann, M. G., & Kuhn, R. J. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb990 · Cited by 459
Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1223-1231.2005 · Cited by 429
A Plaque Reduction Test for Dengue Virus Neutralizing Antibodies
Russell, P. K., Nisalak, A., Sukhavachana, P., & Vivona, S. (1967) · The Journal of Immunology · doi:10.4049/jimmunol.99.2.285 · Cited by 425
New Mouse Model for Dengue Virus Vaccine Testing
Johnson, A. J., & Roehrig, J. T. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.783-786.1999 · Cited by 350
Self-citationEndy, T. P., Nisalak, A., Chunsuttitwat, S., Vaughn, D. W., Green, S., Ennis, F. A., Rothman, A. L., & Libraty, D. H. (2004) · The Journal of Infectious Diseases · doi:10.1086/382280 · Cited by 340
Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981.
Kourí, G., Guzmán, M., Bravo, J., & Triana, C. (1989) · Europe PMC (PubMed Central) · Cited by 328
Kinney, R. M., Butrapet, S., Chang, G.-J. J., Tsuchiya, K. R., Roehrig, J. T., Bhamarapravati, N., & Gubler, D. J. (1997) · Virology · doi:10.1006/viro.1997.8500 · Cited by 320
Self-citationThe Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection
Pierson, T. C., Xu, Q., Nelson, S., Oliphant, T., Nybakken, G. E., Fremont, D. H., & Diamond, M. S. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.03.002 · Cited by 308
Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes
Crill, W. D., & Chang, G.-J. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13975-13986.2004 · Cited by 300
Guirakhoo, F., Pugachev, K., Zhang, Z., Myers, G., Levenbook, I., Draper, K., Lang, J., Ocran, S., Mitchell, F., Parsons, M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4761-4775.2004 · Cited by 253
Pierson, T. C., Sánchez, M. D., Puffer, B. A., Ahmed, A. A., Geiss, B. J., Valentine, L. E., Altamura, L. A., Diamond, M. S., & Doms, R. W. (2006) · Virology · doi:10.1016/j.virol.2005.10.030 · Cited by 224
Stiasny, K., & Heinz, F. X. (2006) · Journal of General Virology · doi:10.1099/vir.0.82210-0 · Cited by 201
Putnak, J. R., Coller, B.-A., Voss, G., Vaughn, D. W., Clements, D. E., Peters, I. D., Bignami, G. S., Houng, H. S., Chen, R. C.-M., Barvir, D. A., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.03.042 · Cited by 171
Blaney, J. E., Matro, J. M., Murphy, B. R., & Whitehead, S. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5516-5528.2005 · Cited by 162
Immunological enhancement of dengue virus replication.
Halstead, S. B., Chow, J. S., & Marchette, N. J. (1973) · PubMed · Cited by 162
A new mechanism for the neutralization of enveloped viruses by antiviral antibody
Gollins, S., & Porterfield, J. S. (1986) · Nature · doi:10.1038/321244a0 · Cited by 152
Sun, W., Edelman, R., Kanesa-thasan, N., et al. (2003) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.69.6_suppl.0690024 · Cited by 144
Rodrigo, W. W. S. I., Jin, X., Blackley, S. D., Rose, R. C., & Schlesinger, J. J. (2006) · Journal of Virology · doi:10.1128/jvi.00792-06 · Cited by 123
Transmission of Dengue 1 and 2 Viruses in Greece in 1928
Halstead, S. B., & PAPAEVANGELOU, G. J. (1980) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1980.29.635 · Cited by 73
DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus
da Costa, S. M., Freire, M. S., & Alves, A. M. B. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.022 · Cited by 61
Antibody-Enhanced Infection of Monocytes as the Pathogenetic Mechanism for Severe Dengue Illness
Kliks, S. C. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.993 · Cited by 60
Stiasny, K., Bressanelli, S., Lepault, J., Rey, F. A., & Heinz, F. X. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3178-3183.2004 · Cited by 59
Cited by
Dengue: a continuing global threat
Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., et al. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2460 · Cited by 2,082
Musso, D., & Gubler, D. J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00072-15 · Cited by 1,469
Cao, Y., Su, B., Guo, X., Sun, W., Deng, Y., Bao, L., Zhu, Q., Zhang, X., Zheng, Y., Geng, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.025 · Cited by 1,188
Sabchareon, A., Wallace, D., Sirivichayakul, C., Limkittikul, K., Chanthavanich, P., Suvannadabba, S., Jiwariyavej, V., Dulyachai, W., Pengsaa, K., Wartel, T. A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61428-7 · Cited by 818
A review of Dengvaxia®: development to deployment
Thomas, S. J., & Yoon, I.-K. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1658503 · Cited by 331
Metadata
- Authors
- Roehrig, J. T., Hombach, J., & Barrett, A. D. T.
- Venue
- Viral Immunology
- Publisher
- SAGE Publications
- Published
- 2008-06
- Volume
- 21
- Issue
- 2
- Pages
- 123-132
- ISSN
- 0882-8245 (ISSN-L)
- 1557-8976
- OpenAlex
- W2104989660
- Cited by
- 450
- References
- 35
- FWCI
- 15.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.